← Leaderboards
Dan Stinchcomb
Inviragen, Inc.
$7,838,531
Attributed
$7,838,531
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2012–13$5M$3.8M$2.5M$1.3M$0
'12
'13
Funding mix
By agency
NIH$7,838,531 · 1
By mechanism
N01$7,838,531 · 1
Top collaborators
No co-investigators on record.
Most similar at Inviragen, Inc.
Same institution · by research overlap
- Dan Thomas Stinchcomb$8,342,763
- Richard M. Kinney$427,627
- Charalambos Partidos$2,828,772
- Jill A. Livengood$373,315
Others in their field
Top investigators on “Advanced Development”
- David Heimbrook · Leidos Biomedical Research, Inc.$625,894,719
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$331,630,794
- David H Reitze · University Of Florida$318,606,363
- Albert Lazzarini · California Institute Of Technology$317,303,333
Research focus
Advanced DevelopmentBiothreatCommunicable DiseasesDengueDisease OutbreaksEventResponseSupport ContractsTechnologyTechnology DevelopmentVaccine DeliveryVaccine DevelopmentVaccines